Abstract
Introduction/BackgroundKnowledge regarding homologous recombination deficiency (HRD) status at diagnosis is essential to manage patients with advanced epithelial ovarian cancer (EOC). These genomic tests are performed on tumor samples and unfortunately...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.